The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKanabo Grp Plc Regulatory News (KNB)

Share Price Information for Kanabo Grp Plc (KNB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.75
Bid: 1.60
Ask: 1.90
Change: 0.00 (0.00%)
Spread: 0.30 (18.75%)
Open: 1.75
High: 1.75
Low: 1.75
Prev. Close: 1.75
KNB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Ian Mattioli as Non-Executive Chair

9 May 2023 07:00

RNS Number : 6715Y
Kanabo Group PLC
09 May 2023
 

9 May 2023

 

Kanabo Group plc

("Kanabo", the "Group" or the "Company")

 

Appointment of Ian Mattioli MBE as Non-Executive Chair of the Board

 

Kanabo Group plc (LSE: KNB), the patient focused healthcare technology and medicinal cannabis company, announces the appointment of Ian Mattioli MBE as Non-Executive Chair with immediate effect.

 

Ian Mattioli, co-founder and CEO of a leading UK pensions and wealth management consultancy, brings extensive experience in financial services, wealth management and capital markets.

 

Key Highlights:

· Co-founder and CEO of Mattioli Woods PLC, a leading UK pensions and wealth management consultancy.

· Ian created and founded the property business Custodian Property Income REIT plc which listed on the London Stock Exchange Main Market in 2014.

· Recipient of London Stock Exchange AIM Entrepreneur of the Year and CEO of the Year in the 2018 City of London Wealth Management Awards.

Mr David Tsur, who has served as the Kanabo's Non-Executive Chair since the Company's admission to the London Stock Exchange in February 2021, will transition to Deputy Chair following Ian Mattioli's appointment.

 

David Tsur, Deputy Chair of Kanabo:

"We are delighted to welcome Ian to the leadership team as we embark on a year of growth and expansion into new markets and services. His experience and understanding of London's capital markets will be invaluable as we work to advance our strategic goals for the company. Since the Company's admission to the London Stock Exchange, we have achieved numerous significant milestones, including launching two medical cannabis products, building a comprehensive supply chain, acquiring The GP Service, and launching Treat-It, our innovative digital health platform for pain management."

 

Ian Mattioli MBE, added:

"I am delighted to join Kanabo as a Chair and am impressed with the Company's commitment to personalised, accessible, and affordable healthcare. With its leading-edge technology and disruptive products, Kanabo is poised for significant growth in the digital health sector. I am keen to contribute my experience and knowledge to support Kanabo in its future success."

 

Additional information about Ian Mattioli MBE

Ian Mattioli brings considerable financial services, wealth management, property and capital markets experience to the Group. Ian Mattioli co-founded the wealth management group, Mattioli Woods PLC ("Mattioli Woods"), in 1991 and has held the role of CEO since Mattioli Woods was admitted to AIM in 2005. He is responsible for the vision and operational management of the Group. Mattioli Woods is one of the UK's leading consultancies in the provision of pensions and wealth management services for controlling directors, professional persons, owner-managed businesses, and small-to-medium-sized PLCs.

 

Ian Mattioli has received many accolades for his business acumen, including being awarded the London Stock Exchange AIM Entrepreneur of the Year award and CEO of the Year in the 2018 City of London Wealth Management Awards. Ian Mattioli was awarded an MBE for services to business and the community in Leicestershire in the Queen's 2017 Honours List. In 2022, the University of Leicester awarded Ian Mattioli an honorary degree (Doctor of Laws).

 

Ian Mattioli is currently Chief Executive Officer of Mattioli Woods Plc, and Non-Executive Director of Custodian Property Income REIT Plc.

 

Save for the information disclosed below, Kanabo confirms there is no further information to be disclosed under the requirements of Listing Rule 9.6.13 in relation to the appointment of Ian Mattioli as Non-Executive Director.

 

Current Directorships

Non-current directorships (past 5 years)

Mattioli Woods Plc

K3 Capital Group Plc

Custodian Property Income REIT Plc

DRUM Income Plus REIT plc

 

Ian Mattioli currently holds 500,000 ordinary shares in the Company, representing 0.1% of the issued share capital.

 

Enquiries:

 

Kanabo Group plc

Avihu Tamir, Chief Executive Officer

Assaf Vardimon, Chief Financial Officer

Ian Mattioli, Non-Executive Chair of the Board

 

via Vigo Consulting

+44 (0)20 7390 0230

Peterhouse Capital Ltd (Financial Adviser and Broker)

Eran Zucker / Lucy Williams / Charles Goodfellow

+44 (0)20 7469 0930

Vigo Consulting (Financial Public Relations/Investor Relations)

Jeremy Garcia / Fiona Hetherington / Verity Snow

kanabo@vigoconsulting.com

 +44 (0)20 7390 0230

 

 

About Kanabo Group Plc

Kanabo Group Plc (LSE:KNB) is a healthtech company committed to revolutionising patient care through its innovative technology platform and disruptive product offerings. Since its inception in 2017, Kanabo has been focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices.

 

Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. The Company is a leader in its field, focusing on improving patient outcomes and providing more accessible healthcare experiences.

 

In March 2023, Kanabo successfully launched its Pain Clinic, Treat It, under the expert guidance of its technological and product expertise. Treat It initially focuses on chronic pain management using plant-based medicine and treatments that are currently unavailable through traditional channels.

 

At Kanabo Group Plc, we are dedicated to providing patients with the highest quality medical treatments and more accessible healthcare experiences.

Visit www.kanabogroup.com for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIGDUIDGDGXI
Date   Source Headline
4th Nov 20217:00 amRNSUpdate on Materia Acquisition
29th Oct 20217:00 amRNSTotal Voting Rights
22nd Oct 20217:00 amRNSHalf-year Report
7th Oct 20217:00 amRNSNew Partnership Agreement
30th Sep 20217:00 amRNSTotal Voting Rights
22nd Sep 20217:00 amRNSCBD Line Launched in the UK on HandpickedCBD.com
14th Sep 20217:05 amRNSMateria Receives Licence for Malta Facility
31st Aug 20211:51 pmRNSTotal Voting Rights
17th Aug 202111:05 amRNSSecond Price Monitoring Extn
17th Aug 202111:00 amRNSPrice Monitoring Extension
17th Aug 20217:00 amRNSUpdate: New contract signed by Materia
2nd Aug 20217:01 amRNSUpdate re: Investment & MoU with Hellenic Dynamics
30th Jul 202112:49 pmRNSTotal Voting Rights
26th Jul 202111:05 amRNSSecond Price Monitoring Extn
26th Jul 202111:00 amRNSPrice Monitoring Extension
26th Jul 20217:00 amRNSProposed Acquisition
22nd Jul 20213:32 pmRNSBlock Listing Application
14th Jul 20217:00 amRNSKanabo’s First Medical Cannabis Product in UK
8th Jul 20211:00 pmRNSIssue of Equity
30th Jun 20217:00 amRNSTotal Voting Rights
29th Jun 20217:00 amRNSAppointment of Director & Grant of Options
28th Jun 20213:41 pmRNSResult of AGM
25th Jun 20217:00 amRNSInitial Commercial Scale Production
24th Jun 20213:58 pmRNSIssue of Equity
17th Jun 20212:59 pmRNSIssue of Equity
4th Jun 20217:00 amRNSSupport for New Campaign
3rd Jun 202112:00 pmRNSNotice of AGM
2nd Jun 20219:26 amRNSAnnual Financial Report
26th May 20213:36 pmRNSAdmission of Placing Shares
24th May 20217:00 amRNSPlacing, Investment & MoU with Hellenic Dynamics
20th May 20217:00 amRNSNew EU GMP CBD Manufacturing Agreement
14th May 20212:00 pmRNSIssue of Equity
11th May 20211:09 pmRNSIssue of Equity
6th May 20212:00 pmRNSIssue of Equity
26th Apr 20213:03 pmRNSIssue of Equity
21st Apr 20212:57 pmRNSIssue of Equity
14th Apr 20214:01 pmRNSIssue of Equity
8th Apr 20213:15 pmRNSQ1 Summary
31st Mar 20214:51 pmRNSTotal Voting Rights
30th Mar 20213:26 pmRNSIssue of Equity
26th Mar 20217:00 amRNSPDMR Notification
23rd Mar 20218:47 amRNSPublication of Research Note
16th Mar 20212:42 pmRNSIssue of Equity
9th Mar 202111:06 amRNSSecond Price Monitoring Extn
9th Mar 202111:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSMedicinal Cannabis Production Agreement
8th Mar 20213:42 pmRNSChange of Registered Address
23rd Feb 20217:00 amRNSUK Medicinal Cannabis Distribution Agreement
22nd Feb 20219:05 amRNSSecond Price Monitoring Extn
22nd Feb 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.